The challenge of policy-making for the new life sciences

The Limits to Governance: The Challenge of Policy-making for the New Life Sciences

Volumn , Issue , 2009, Pages 1-17

  Lyall, Catherine ^a   Papaioannou, Theo ^b   Smith, James ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958825057     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. 6, P. (2005), 'The Governance of Technology', in Lyall, C. and Tait, J. (eds) New Modes of Governance. Developing an Integrated Policy Approach to Science, Technology, Risk and the Environment (Aldershot: Ashgate).
2. Abraham, J., Sheppard, J. and Reed, T. (1999), 'Rethinking Transparency and Accountability in Medicines Regulation in the United Kingdom', British Medical Journal 318, 46-7.
3. Abraham, J. (2002), 'The Pharmaceutical Industry as a Political Player', The Lancet 360:9, 1498-502.
4. Anon (2005), 'When Disenchantment Leads to Disengagement', Research Fortnight 26:January 2005, 18-19.
5. Atkinson, M.M. and Coleman, W.D. (1992), 'Policy Networks, Policy Communities and the Problems of Governance', Governance: An International Journal of Policy and Administration 5:2, 154-80.
6. Bache, I. (2003), 'Governing through Governance: Education Policy Control under New Labour', Political Studies 51:2, 300-314.
7. Barry, A. (2001), Political Machines: Governing a Technological Society (London and New York: The Athlone Press).
8. Barry, A. (2003), Carrots, Sticks and Sermons: Policy Instruments and their Evaluation (New Brunswick, NJ: Transaction Publishers).
9. Bevir, M., Rhodes, R.A.W. and Weller, P. (2003a), 'Comparative Governance: Prospects and Lessons', Public Administration 81:1, 191-210.
10. Bevir, M., Rhodes, R.A.W. and Weller, P. (2003b), 'Traditions of Governance: Interpreting the Changing Role of the Public Sector', Public Administration 81:1, 1-17.
11. Bonnicksen, A.L. (2002), Crafting a Cloning Policy. From Dolly to Stem Cells (Washington DC: Georgetown University Press).
12. Borzel, T.A. (1998), 'Organizing Babylon - on the Different Conceptions of Policy Networks', Public Administration 76:Summer, 253-73.
13. Bowe, C. (2004a), 'FDA Expert Accuses Agency over Vioxx', Financial Times. (London, 18 November 2004).
14. Bowe, C. (2004b), 'FDA Official Warns on More Drugs in Hearing', Financial Times (London, 19 November 2004).
15. Bowe, C. (2004c), 'Safety Fears Plague US Drug System', Financial Times (London, 25 November 2004).
16. Chataway, J., Tait, J. and Wield, D. (2006), 'The Governance of Agro- and Pharmaceutical Biotechnology Innovation: Public Policy and Industrial Strategy', Technology Analysis and Strategic Management 18:2, 169-85.
17. Clark, N., Mugabe, J. and Smith, J. (2007), Governing Biotechnology in Africa (Nairobi: African Centre of Technology Studies).
18. Common, R. (2004), 'Organisational Learning in a Political Environment. Improving Policy-making in UK Government', Policy Studies 25:1, 35-49.
19. Davies, J.S. (2005), 'Local Governance and the Dialectics of Hierarchy, Market and Network', Policy Studies 26:3/4, 311-35.
20. DTI (2004), The DTI Five-year Programme. Creating Wealth from Knowledge (London: DTI/Pub 7613/0.5k/11/04/NP.URN 04/1871).
21. Eberlein, B. and Kerwer, D. (2004), 'New Governance in the European Union: A Theoretical Perspective', Journal of Common Market Studies 42:1, 121-42.
22. European Commission (2005), 'Social Values, Science and Technology', Special Eurobarometer Report (Brussels: June 2005) http://europa.eu.int/comm/public_opinion/archives/ebs/ebs_225_report_en.pdf.
23. Firn, D. (2004a), 'Inquiry into Drug Companies Launched', Financial Times (London: 10 September 2004).
24. Firn, D. (2004b), 'FDA Safety Official Complains of Intimidation over Vioxx', Financial Times (London: 24 November 2004).
25. Forbes, I. (2006), 'States of Uncertainty: Governing the Empire of Biotechnology', New Genetics and Society 25:1, 70-88.
26. Frantz, S. (2005), 'How to avoid another "Vioxx"', Nature Reviews Drug Discovery 4, 5-7 (January 2005).
27. Gottweis, H. (2002), 'The Governance of Genomics', Critical Public Health 12:3, 207-20.
28. Greenaway, J., Salter, B. and Hart, S. (2007), 'How Policy Networks Can Damage Democratic Health: A Case Study in the Government of Governance', Public Administration 85:3, 717-38.
29. Hagendijk, J. and Irwin, A. (2006), 'Public Deliberation and Governance: Engaging with Science and Technology in Contemporary Europe', Minerva 44:2, 167-84.
30. Hay, C. and Richards, D. (2000), 'The Tangled Webs of Westminster and Whitehall: The Discourse, Strategy and Practice of Networking within the British Core Executive', Public Administration 78:1, 1-28.
31. Hood, C. (1986), The Tools of Government (Chatham: Chatham House Publishers).
32. House of Commons Health Committee (2004), The Influence of the Pharmaceutical Industry (London: House of Commons).
33. Howlett, M. (1991), 'Policy Instruments, Policy Styles, and Policy Implementation: National Approaches to Theories of Instrument Choice', Policy Studies Journal 19:2, 1-21.
34. Ismail, M.A. (2005), Drug Lobby Second to None July 2005 (Washington DC: Center for Public Integrity).
35. Jordan, A., Wurzel, R.K.W. and Zito, A. (2005), 'The Rise of "New" Policy Instruments in Comparative Perspective: Has Governance Eclipsed Government?', Political Studies 53, 477-96.
36. Kjaer, A.M. (2004), Governance (Cambridge: Polity).
37. Kooiman, J. (1993), Modern Governance. New Government-Society Interactions (London: Sage).
38. Lyall, C. (2007a), 'Governing Genomics: New Governance Tools for New Technologies?', Technology Analysis and Strategic Management 19:3, 365-82.
39. Lyall, C. (2007b), 'Changing Boundaries: The Role of Policy Networks in the Multi-level Governance of Science and Innovation in Scotland', Science and Public Policy 34:1, 3-14.
40. Lyall, C. and Tait, J.(2005), 'A New Mode of Governance for Science, technology, Risk and the Environment?', in Lyall, C. and Tait, J. (eds) New Modes of Governance. Developing an Integrated Policy Approach to Science, Technology, Risk and the Environment (Aldershot: Ashgate).
41. Marinetto, M. (2003), 'Governing beyond the Centre: A Critique of the Anglo-Governance School', Political Studies 51:3, 592-608.
42. Marris, E. (2004), 'Suppressed Study Raises Spectre of Flawed Drug Regulation in US', Nature 432, 537.
43. McComas, K.A., Tuite, L.S. and Sherman, L.A. (2005), 'Conflicted Scientists: The "Shared Pool" Dilemma of Scientific Advisory Committees', Public Understanding of Science 14:3, 285-303.
44. Michaels, D. and Wagner, W. (2003), 'Disclosure in Regulatory Science', Science 302, 2073.
45. Mitchell, P. (2004), '"Self-interested" FDA Accepts Reform after Vioxx Fiasco', Chemistry and Industry 22:4 (15 November 2004).
46. Mitchell, P. (2005), 'Europe Caught in Innovation Quagmire', Nature Biotechnology 23:9, 1029.
47. Murphy, J. and Chataway, J. (2005), 'The Challenges of Policy Integration from an International Perspective: The Case of GMOs', in Lyall, C. and Tait, J. (eds) New Modes of Governance. Developing an Integrated Policy Approach to Science, Technology, Risk and the Environment (Aldershot: Ashgate).
48. Newman, J. (2001), Modernising Governance. New Labour, Policy and Society (London: Sage).
49. Osborne, D. and Gaebler, T. (1992), Re-inventing Government (Reading, MA: Addison-Wesley).
50. Pierre, J. and Peters, B.G. (2000), Governance, Politics and the State (Basingstoke: Macmillan).
51. Rhodes, R.A.W. (1997), Understanding Governance. Policy Networks, Governance, Reflexivity and Accountability (Buckingham: Open University Press).
52. Rhodes, R.A.W. and Marsh, D. (1992), 'New Directions in the Study of Policy Networks', European Journal of Political Research 21, 181-205.
53. Ringeling, A.B. (2002), 'European Experience with Tools of Government', in Salamon, L.M. (ed.) The Tools of Government (New York: Oxford University Press).
54. Salamon, L.M. (2002a), 'The New Governance and the Tools of Public Action: An Introduction', in Salamon, L.M. (ed.) The Tools of Government (New York: Oxford University Press).
55. Salamon, L.M. (2002b), 'The Tools Approach and the New Governance: Conclusion and Implications', in Salamon, L.M. (ed.) The Tools of Government (New York: Oxford University Press).
56. Schneider, A. and Ingram, H. (1990), 'Behavioural Assumptions of Policy Tools', Journal of Politics 52:2, 510-29.
57. Sloat, A. (2002), 'Governance: Contested Perceptions of Civic Participation', Scottish Affairs 39:Spring, 103-17.
58. Stoker, G. (1998), 'Governance as Theory: Five Propositions', International Social Science Journal 50:155, 17-28.
59. Tait, J., Chataway, J., Lyall, C. and Wield, D. (2006), 'Governance, Policy and Industry Strategies: Pharmaceuticals and Agro-biotechnology', in Mazzucato, M. and Dosi, G. (eds) Innovation, Growth and Market Structure in High-tech Industries: The Case of Biotech-Pharmaceuticals (Cambridge: Cambridge University Press).
60. Thompson, G.F. (2003), Between Hierarchies and Markets. The Logic and Limits of Network Forms of Organisation (Oxford: Oxford University Press).
61. Zito, A.R., Radaelli, C.M. and Jordan, A. (2003), 'Introduction to the Symposium on "New" Policy Instruments in the European Union', Public Administration 81:3, 509-11.